SFRS2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62725388719309E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.10900000294123E-09 |
Normal-vs-Stage2 |
1.83733999999935E-05 |
Normal-vs-Stage3 |
2.18647322469678E-12 |
Normal-vs-Stage4 |
<1E-12 |
Stage1-vs-Stage2 |
2.680800E-01 |
Stage1-vs-Stage3 |
2.803300E-03 |
Stage1-vs-Stage4 |
3.60110000041658E-07 |
Stage2-vs-Stage3 |
3.889000E-01 |
Stage2-vs-Stage4 |
3.786100E-02 |
Stage3-vs-Stage4 |
1.021360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62581059726108E-12 |
Normal-vs-AfricanAmerican |
2.47679999999528E-05 |
Normal-vs-Asian |
4.016300E-02 |
Caucasian-vs-AfricanAmerican |
2.282200E-01 |
Caucasian-vs-Asian |
6.456600E-01 |
AfricanAmerican-vs-Asian |
3.627000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
2.2709000235821E-09 |
Male-vs-Female |
1.342030E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.98440000384903E-09 |
Normal-vs-Age(41-60Yrs) |
2.45281572830436E-12 |
Normal-vs-Age(61-80Yrs) |
4.08562073062058E-14 |
Normal-vs-Age(81-100Yrs) |
1.278070E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.860580E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.868200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.777970E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.781000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.856400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.419000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.710550E-01 |
Normal-vs-Grade 2 |
6.43419999502015E-08 |
Normal-vs-Grade 3 |
1.62636570877339E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
8.850400E-02 |
Grade 1-vs-Grade 3 |
1.596030E-02 |
Grade 1-vs-Grade 4 |
2.05580000000039E-05 |
Grade 2-vs-Grade 3 |
9.609500E-04 |
Grade 2-vs-Grade 4 |
3.01629998755715E-09 |
Grade 3-vs-Grade 4 |
2.019700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.552900E-04 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
5.58442181386454E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.64535052249448E-12 |
Normal-vs-N1 |
3.47909479003761E-11 |
N0-vs-N1 |
2.275900E-02 |
|
|